Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01918891 · ClinicalTrials.gov registry record · NA
Center for Stroke Disparities Solution - Community Transitions Intervention
A NA study of Hypertension and Stroke, sponsored by Visiting Nurse Service of New York.
- Completed
- Registry status
- NA
- Development phase
- 495
- Enrollment target
- 1
- Study location
NCT01918891: Completed NA study of Hypertension and Stroke, sponsored by Visiting Nurse Service of New York.
NCT01918891 is a NA study of Hypertension and Stroke that has completed, run by Visiting Nurse Service of New York. The registered enrollment target is 495 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01918891, a NA study of Hypertension and Stroke, has completed, sponsored by Visiting Nurse Service of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 495 participants
- Enrollment target
- 1
- Study location
Study Summary
The Stroke CTI study is a 3 arm randomized, controlled trial designed to assess the effectiveness of a nurse practitioner (NP) only and a NP and health coach (HC) community transitions intervention (CTI) in reducing secondary stroke risk by helping patients lower their systolic blood pressure.
Primary Outcome
Patients randomized to the NP only and the NP+HC transitional care interventions will have greater 3 and 12 month reduction in SBP than patients in Usual Home Care.
Conditions Studied
Interventions
- BEHAVIORAL Nurse Practitioner Only
- BEHAVIORAL Nurse Practitioner + Health Coach
Study Locations (1)
New York
- Visiting Nurse Service of New York - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 495 participants |
| Start Date | 2012-09 |
| Est. Completion | 2018-06 |
| Phase | NA |
What the finished NCT01918891 record still lists
NCT01918891 is an interventional study that assigns participants to a tested intervention. The registered 495 participants enrollment target is mid-sized for trials with a published cap, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Nurse Practitioner Only is the first listed.
NCT01918891 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01918891 about?
NCT01918891 is a clinical study titled "Center for Stroke Disparities Solution - Community Transitions Intervention". The Stroke CTI study is a 3 arm randomized, controlled trial designed to assess the effectiveness of a nurse practitioner (NP) only and a NP and health coach (HC) community transitions intervention (CTI) in reducing secondary stroke risk by helping patients lower their systolic blood pressure.
What is the current status of trial NCT01918891?
This trial is currently completed. It is a NA study. The enrollment target is 495 participants. The study started on 2012-09. Estimated completion is 2018-06.
What conditions does trial NCT01918891 study?
This clinical trial studies the following conditions: Hypertension, Stroke, Transient Ischemic Attack.
What interventions are being tested in trial NCT01918891?
The interventions under investigation include: Nurse Practitioner Only (BEHAVIORAL), Nurse Practitioner + Health Coach (BEHAVIORAL).
Who is sponsoring clinical trial NCT01918891?
This trial is sponsored by Visiting Nurse Service of New York, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01918891 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01918891's enrollment target sits among peer trials
495 123rd of 470 higher than 348 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127267 · 495 participants · Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- NCT06400472 · 495 participants · Phase 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia